The 5T's of health disparities in multiple myeloma in Latin America.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-11-01 Epub Date: 2024-09-07 DOI:10.1097/CCO.0000000000001088

Humberto Martinez-Cordero, Cynthia Fuentes-Lacouture, Alana von Glasenapp, Camila Peña

{"title":"The 5T's of health disparities in multiple myeloma in Latin America.","authors":"Humberto Martinez-Cordero, Cynthia Fuentes-Lacouture, Alana von Glasenapp, Camila Peña","doi":"10.1097/CCO.0000000000001088","DOIUrl":null,"url":null,"abstract":"Purpose of review: Health disparities or inequities, which are defined as differences in the quality of medical and healthcare between populations among racial, ethnic, and socioeconomic groups, have been validated in numerous studies as determinants of survival and quality of life in different diseases, including cancer.Compared to the improvement in overall survival in developed countries in relation to better diagnostic opportunity and novel therapeutic approaches, low and middle-income countries still have significant barriers in accessing these therapies.The potential impact of overcoming these barriers is immense and offers hope for better outcomes.Recent findings: There is great heterogeneity in the diagnostic and therapeutic approach to multiple myeloma among different latitudes. Latin America has been characterized by important limitations in using the best technologies currently available in developed countries.Summary: Overcoming health disparities in multiple myeloma in LMICs could help improve survival and quality of life outcomes. Likewise, it is necessary to increase the representation of the Latin population in clinical studies, primarily in our region.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CCO.0000000000001088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Health disparities or inequities, which are defined as differences in the quality of medical and healthcare between populations among racial, ethnic, and socioeconomic groups, have been validated in numerous studies as determinants of survival and quality of life in different diseases, including cancer.Compared to the improvement in overall survival in developed countries in relation to better diagnostic opportunity and novel therapeutic approaches, low and middle-income countries still have significant barriers in accessing these therapies.The potential impact of overcoming these barriers is immense and offers hope for better outcomes.

Recent findings: There is great heterogeneity in the diagnostic and therapeutic approach to multiple myeloma among different latitudes. Latin America has been characterized by important limitations in using the best technologies currently available in developed countries.

Summary: Overcoming health disparities in multiple myeloma in LMICs could help improve survival and quality of life outcomes. Likewise, it is necessary to increase the representation of the Latin population in clinical studies, primarily in our region.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

拉丁美洲多发性骨髓瘤的 5T 健康差异。

审查目的：健康差异或不平等是指不同种族、民族和社会经济群体之间在医疗和保健质量方面的差异，已被大量研究证实是包括癌症在内的不同疾病的生存和生活质量的决定因素。与发达国家因更好的诊断机会和新型治疗方法而提高的总体生存率相比，中低收入国家在获得这些治疗方法方面仍存在重大障碍：不同纬度地区的多发性骨髓瘤诊断和治疗方法存在很大差异。总结：在低收入和中等收入国家，克服多发性骨髓瘤的健康差异有助于提高生存率和生活质量。同样，有必要增加拉丁人群在临床研究中的代表性，主要是在本地区。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊